v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities        
Net loss for the period $ (14,823,762) $ (2,039,675) $ (9,364,552) $ (4,670,011)
Adjustments to reconcile net loss to cash for operating activities        
Depreciation and amortization 4,535 77,611 504,732 66,081
Accretion of debt discount and issuance cost 1,203,851 35,529 415,094 2,120,640
Inducement expense     17,840 1,465,308
Stock based compensation 11,307,992 949,924 8,190,246 9,442,717
Unrealized loss (gain) on marketable securities 155,688 (58,019) (166,114)
Impairment of goodwill     35,723
Impairment of intangible assets     35,723
Change in fair value of derivative liabilities (270,784) 992,731 (7,836,522)
Loss from discontinued operations 466,499    
Loss on disposal of discontinued operations 912,840    
Gain on extinguishment of debt (9,238) (729,304) (413,903)
Amortization of right of use asset 18,519 144,138 121,655
Settlement of liabilities     (3,749,308) (3,726,317)
Non-controlling interest in consolidated subsidiary     2,555,059
Loss (gain) settlement of liabilities 2,376 (105,605)    
Changes in operating assets and liabilities (net of acquired amounts):        
Accounts receivable 5,000 (24,327) (9,530) 2,000
Prepaid expenses and other current assets 88,575 21,875 (332,021)
Deposits and other assets 9,291 10,164
Deferred revenue (211,201) 88,697 (89,942) (119,087)
Change in operating lease liabilities (7,289) (1,231,335) (303,415)
Accounts payable and accrued liabilities (150,313) 332,201 1,143,363 1,916,129
Net cash used in operating activities (1,308,704) (710,506) 3,918,886  
Cash flows from investing activities:        
Cash received in consideration for disposal of business, net of cash divested 993,332    
Purchases of property and equipment (12,436) (5,060)
Cash paid for marketable securities, net of proceeds    
Net cash provided by investing activities 980,896 (5,060)
Cash flows from financing activities:        
Proceeds from issuance of notes payable and warrants 164,500    
Proceeds from issuance of convertible notes 300,000 2,212,778 300,000
Proceeds from issuance of common stock and warrants     276,140 221,600
Proceeds from issuance of preferred stock (Creatd)     1,901,000 210,000
Proceeds from the exercise of warrant     2,000
Proceeds from issuance of notes payable     813,829 430,730
Repayment of notes payable (107,555) (71,768) (580,915) (339,277)
Repayment of convertible notes (3,600) (395,699) (326,173)
Proceeds from issuance of preferred stock 1,231,000    
Proceeds from issuance of common stock 276,140    
Net cash provided by financing activities 356,945 1,431,772 4,229,133 496,880
Effect of exchange rate changes on cash (358) (688) (123,574)
Net increase in cash and cash equivalents 29,137 720,908 231,923 (57,765)
Cash and cash equivalents at beginning of period 221,742 15,490 15,490  
Cash and cash equivalents at end of period 250,879 736,398 221,742 15,490
Supplemental disclosure of cash flow information:        
Cash paid for interest 36,672 8,895 67,806 61,829
Cash paid for income taxes
Supplemental disclosure of non-cash investing and financing activities:        
Stock issued for acquisition of business 14,072,253    
Goodwill recognized in acquisition of business 8,085,003    
Intangible assets recognized in acquisition of business 7,821,867    
Warrants issued with debt     1,561,525 356,796
Shares issued with debt 2,122 2,123 78,256
Stock paid for acquisitions     14,072,315 109,000
Stock paid for marketable securities, net of rescission of Enzylotics     16,257 67,641
Stock paid for minority investments     839,500 333,333
Common stock issued upon conversion of notes payable     1,110,104 1,377,250
Non-cash settlement of liabilities 9,158 579,548
Derivative liability at inception     1,329,072
Deemed dividend     2,071,047 33,017,888
Preferred stock receivable in consideration for disposal of business 5,614,086    
Promissory Note Receivable issued in consideration for disposal of business 4,787,469    
Liabilities assumed as consideration for disposal of business 239,446    
Debt discount recorded on issuance of convertible note from equity classified warrants 238,170    
Day 1 bifurcation of embedded derivative on convertible note 61,830    
Previously Reported        
Adjustments to reconcile net loss to cash for operating activities        
Inducement expense     17,840
Impairment of goodwill     226,613
Gain on extinguishment of debt     (729,304)
Changes in operating assets and liabilities (net of acquired amounts):        
Net cash used in operating activities     (3,991,462) (431,071)
Cash flows from financing activities:        
Cash and cash equivalents at beginning of period $ 247,413 $ 15,490 15,490 73,255
Cash and cash equivalents at end of period     $ 247,413 $ 15,490